Beit Jala Pharmaceutical Company (PEX:BJP)

PEX:BJP Revenue

Beit Jala Pharmaceutical Company had revenue of 2.81M JOD in the quarter ending March 31, 2026, a decrease of -13.42%. This brings the company's revenue in the last twelve months to 12.34M, up 15.74% year-over-year. In the year 2025, Beit Jala Pharmaceutical Company had annual revenue of 12.78M with 32.28% growth.

• Revenue (ttm): 12.34M
• Revenue Growth: +15.74%
• P/S Ratio: 2.05
• Revenue / Employee: 56.09K
• Employees: 220
• Market Cap: 25.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.78M	3.12M	32.28%
Dec 31, 2024	9.66M	51.85K	0.54%
Dec 31, 2023	9.61M	-1.16M	-10.73%
Dec 31, 2022	10.77M	1.01M	10.37%
Dec 31, 2021	9.76M	1.07M	12.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error